September 1, 2016, Coralville, IA. – Emmyon is delighted to announce that its Senior Scientific Advisor, Dr. John Talley, has been named, for the second year in a row, to the highly prestigious Power List of The Medicine Maker magazine.  In the 2016 Power List, Dr. Talley was named as the world’s 17th most influential person in drug discovery and development.

April 1, 2016, Coralville, IA – Emmyon is pleased to announce that it has received a new Phase I SBIR award from the National Institutes of Health.  The funding will support development of pharmaceuticals for skeletal muscle atrophy and weakness.

August 19, 2016, Coralville, IA – In collaboration with colleagues at the University of Iowa and the Buck Institute for Research on Aging, Emmyon scientists Chris Adams, Scott Ebert and Mike Dyle published a new paper today describing a previously unknown mechanism of skeletal muscle atrophy.

The paper, entitled “Gadd45a promotes skeletal muscle atrophy by forming a complex with the protein kinase MEKK4” was published in The Journal of Biological Chemistry.  The paper was selected as a JBC Paper of the Week and was selected for the journal cover.  To view the paper, please click here.

September 3, 2015, Coralville, IA. – Emmyon scientists Scott Ebert, John Talley and Christopher Adams published a new paper today describing ursolic acid and tomatidine as natural compounds that reduce muscle loss and weakness during aging. The paper, published in The Journal of Biological Chemistry, may be found here.

September 21, 2015, Washington D.C. – Emmyon research was featured today in Chemical and Engineering News, a publication of the American Chemical Society. The article, “Chemical Fountain of Youth Explained,” may be found below:

March 24, 2015, Coralville, IA. – Emmyon scientists Chris Adams and Scott Ebert were invited to write a new paper that summarizes their research to date on ursolic acid and tomatidine. The paper, published in Current Opinion in Clinical Nutrition and Metabolic Care, may be found here.